Advanced Heart Failure and Transplant Cardiology · New York, NY
NPI
1356604607
Since 2012
Specialty
Advanced Heart Failure and Transplant Cardiology
Code 207RA0001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
173 Fort Washington Ave
New York, NY, 10032
Phone (212) 305-4600
Groups this clinician bills Medicare through
Medicare paid, 2024
$74K
1,357 services
Medicare patients, 2024
310
Average age 72
Drug cost, 2024
$12.8M
3,391 prescriptions
Company payments, 2025
$19K
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yevgeniy Brailovsky was code 93010 (electrocardiogram), 468 times for 242 patients. In total Yevgeniy Brailovsky billed 1,357 services in 26 codes, and Medicare paid $74K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-11-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93010 Electrocardiogram | Facility | 468 | 242 | $6.17 | $2,887 |
| 99233 Hospital E&M - Subsequent | Facility | 272 | 63 | $94.69 | $26K |
| 93750 External Electrocardiographic Monitoring | Facility | 173 | 27 | $32.07 | $5,549 |
| 99214 Office E&M - Established | Facility | 107 | 81 | $71.12 | $7,610 |
| 99215 Office E&M - Established | Facility | 68 | 53 | $104.99 | $7,139 |
| 99291 Critical Care E&M | Facility | 61 | 15 | $170.63 | $10K |
| 93010 Electrocardiogram | Office | 20 | 16 | $6.50 | $130 |
| 99223 Hospital E&M - Initial | Facility | 17 | 16 | $139.17 | $2,366 |
| 99214 Office E&M - Established | Office | 17 | 16 | $77.23 | $1,313 |
| 99204 Office E&M - New | Facility | 16 | 16 | $97.96 | $1,567 |
| 99222 Hospital E&M - Initial | Facility | 15 | 15 | $104.94 | $1,574 |
| 93451 Percutaneous Transcatheterization | Facility | 15 | 13 | $99.13 | $1,487 |
| 93000 Electrocardiogram | Office | 14 | 14 | $7.58 | $106 |
| 99215 Office E&M - Established | Office | 13 | 11 | $118.80 | $1,544 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 11 | 11 | $12.03 | $132 |
By year: 2022 $84K for 958 services; 2023 $92K for 1,143 services; 2024 $74K for 1,357 services.
Medicare prescription drug claims, 2024
In 2024, the drug Yevgeniy Brailovsky prescribed most often to Medicare patients was Vyndamax (Tafamidis), with 457 prescriptions and refills. In total Yevgeniy Brailovsky wrote 3,391 Medicare prescriptions that cost $12.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vyndamax Tafamidis | 457 | 483 | 51 | $10.6M |
| Entresto Sacubitril/Valsartan | 236 | 384 | 49 | $249K |
| Spironolactone Generic | 175 | 455 | 61 | $1,219 |
| Atorvastatin Calcium Generic | 173 | 438 | 57 | $2,856 |
| Metoprolol Succinate Generic | 158 | 378 | 43 | $2,287 |
| Warfarin Sodium Generic | 132 | 284 | 33 | $1,611 |
| Furosemide Generic | 129 | 254 | 38 | $657 |
| Carvedilol Generic | 128 | 285 | 35 | $1,161 |
| Jardiance Empagliflozin | 124 | 195 | 26 | $111K |
| Eliquis Apixaban | 117 | 191 | 26 | $114K |
| Farxiga Dapagliflozin Propanediol | 87 | 130 | 22 | $72K |
| Torsemide Generic | 74 | 168 | 27 | $2,354 |
| Amlodipine Besylate Generic | 70 | 170 | 21 | $527 |
| Rosuvastatin Calcium Generic | 70 | 170 | 19 | $1,122 |
| Amiodarone Hcl Generic | 59 | 123 | 18 | $2,889 |
Brand drugs: - claims; generic drugs: 2,145 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yevgeniy Brailovsky $19K ($19K in general payments such as food, travel and fees) from 12 companies. The largest payer was Alnylam Pharmaceuticals Inc. with $8,412.
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. ALNY | 11 | $8,412 |
| Pfizer Inc. PFE | 4 | $5,686 |
| BridgeBio Pharma, Inc. BBIO | 3 | $2,721 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $1,238 |
| Abbott Laboratories ABT | 4 | $323 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $94.08 |
| Impulse Dynamics (USA) Inc. | 1 | $49.25 |
| Scpharmaceuticals Inc. SCPH | 1 | $36.81 |
| Merck Sharp & Dohme LLC MRK | 1 | $14.58 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $14.2 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.